MMA
AMPE

Miracle Mile Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Miracle Mile Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-133
Closed -$25K – 418
2020
Q2 		$25K Buy
133
+66
+99% +$11K ﹤0.01% 305
2020
Q1 		$8K Hold
67
– – ﹤0.01% 271
2019
Q4 		$12K Buy
+67
New +$8.65K ﹤0.01% 297

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Miracle Mile Advisors's AMPE Position: Q3 2020 in Review

Miracle Mile Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2020, closing a stake of 133 shares — an estimated $25K sold.

Miracle Mile Advisors first reported a position in AMPE in Q4 2019 and held it in 3 quarters. The position peaked at $25K in Q2 2020. 81 funds tracked by Wall St. Rank hold AMPE as of Q3 2020.

  • Miracle Mile Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2020 after selling out during the quarter.
  • Miracle Mile Advisors sold 133 Ampio Pharmaceuticals Inc. shares in Q3 2020, an estimated $25K.
  • Miracle Mile Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q4 2019 and held it in 3 quarters.
  • Miracle Mile Advisors's Ampio Pharmaceuticals Inc. position peaked at $25K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2020.

Based on Miracle Mile Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.